Effects of DN-9693, a selective inhibitor of cyclic AMP phosphodiesterase, in isolated and perfused canine large coronary arteries.
In isolated canine epicardial coronary arteries perfused with Krebs-Henseleit solution at 37 degrees C, DN-9693, a newly synthesized selective cyclic AMP phosphodiesterase inhibitor, induced vasodilation in a dose-related manner. The threshold dose for inducing vasodilation to DN-9693 was very small, but the maximum vasodilation was not great. The order of potency for ED20 (20% dilatation) was DN-9693 greater than IBMX greater than aminophylline, but that for ED70 was IBMX greater than aminophylline greater than DN-9693, suggesting that these three PDE inhibitors have different properties.